ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company

  • Website: http://www.imclone.com/
  • Size: 1,001-5,000 employees
  • Overview: ImClone Systems is a fully integrated global biopharmaceutical company committed to advancing oncology care by developing and commercializing a portfolio of targeted biologic treatments designed to address the medical needs of patients with a variety of cancers. On November 24, 2008, ImClone Systems became a wholly-owned subsidiary of Eli Lilly and Company (NYSE: LLY).

Search 1.5 billion
Email & Phone#

Browse to anyone's Linkedin profile, and Contactout will find that person's email address and phone number

Start your free trial
(300+ Reviews)

People also viewed these companies

  • Writing and Editing
  • Nonprofit Organization Management
  • Construction
  • Computer Software
  • Information Technology and Services
  • Hospital & Health Care
  • Hospital & Health Care
  • Marketing and Advertising
  • Marketing and Advertising